Desjarlais John R

Avg. Two Year Performance

No purchase track record

(17%) Avg. Sale Return

(8%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	6%	3%	8%	7%	(17%)
Sale Success Rate	6 of 9	5 of 9	5 of 9	5 of 9	2 of 9

Xencor Inc

Drugs » Biotechnology

SR. VICE PRESIDENT & CSO:

Holdings: 186.43K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--